logo
logo
Sign in

Prils Market: Global Analysis, Industry Growth, Current Trends and Forecast till 2027

avatar
Mayur Kasrung
Prils Market: Global Analysis, Industry Growth, Current Trends and Forecast till 2027

Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific & the Middle East & Africa) - Global Forecast till 2027

Market Research Future (MRFR) recognizes the following companies as the key players in the global prils market are Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG.

Market Highlights

The Prils Market is estimated to be valued at USD 2,591.5 million by 2023 and is expected to register a CAGR of 4.3% during the forecast period.

Prils are small molecules or active pharmaceutical ingredients (API). APIs are important biological components which are used in drugs because of their therapeutic properties. There are various types of APIs used by pharmaceutical companies to develop therapeutic products for the treatment of various chronic diseases such as hypertension, heart diseases, and kidney diseases.

Segment analysis

On the basis of type, the global prils market is segmented into benazepril, cilazapril, quinapril, and ramipril. These APIs are prescribed as antihypertension drugs with different concentrations. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and mostly preferred drug for the treatment of hypertension. The use of ramipril reduces the risk of stroke, heart attack, and also decreases kidney-related problems. This drug normalizes blood vessels and offers normal blood flow. Ramipril is expected to dominate the prils type segment as it is a highly prescribed drug to patients with heart diseases because it easily binds to a higher degree of binding to angiotensin-converting enzyme (ACE) in vascular tissue and prevents the rise of hypertension.

Similarly, there are other APIs such as benazepril, cilazapril, and quinapril possessing similar properties and are preferred to treat various chronic diseases

The global prils market, based on application, is segmented into hypertension, heart failure, chronic kidney disorders, and others. On the basis of segment, hypertension is estimated to dominate the global prils market owing to the increasing prevalence of cardiovascular diseases and rising geriatric population with heart-related problems. Increasing smoking also causes cardiovascular diseases. The heart failure segment is expected to be the second largest market in 2018.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7692

Regional Analysis

Geographically, the global prils market has been segmented into North America, Europe, Asia-Pacific, and the rest of the world. As per MRFR analysis, the Americas dominated the global prils market and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. Rise in therapeutics industry due to the increasing prevalence of various chronic diseases is boosting the global prils market.

Key Findings of the Study:

  • The global prils market is projected to reach over 2,591.5 million by 2023 with 4.3% CAGR during the review period of 2018 to 2023
  • Americas accounted for the largest share due to the presence of a huge patient population, rapid development in technology, and the presence of huge opportunities for the development of the market drive the growth of the prils market in America.
  • By type, Ramipril is projected to value 1,483.9 million in 2023.
  • Some of the additional players operating in the prils market are Albemarle Corporation, Allergan PLC, Cambrex Corporation, DR. Reddy’s Laboratories Ltd, Lonza, GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd.

Table of Content

1 Executive Summary

2 Market Introduction

2.1 Scope Of The Study 13

2.2 Research Objective 13

2.3 List Of Assumptions 14

3 Research Methodology

3.1 Research Process 15

3.2 Primary Research 16

3.3 Secondary Research 17

3.4 Market Size Estimation 18

4 Market Dynamics

4.1 Introduction 19

4.2 Drivers 20

4.2.1 Growing Pharmaceutical Industry 20

4.2.2 Growing Prevalence Of Chronic Diseases Across The World 20

4.2.3 Growing Importance Of Generic Drugs 20

4.3 Restraints 21

4.3.1 Stringent Regulatory Policies 21

4.3.2 Adverse Drug Price Control Policies Across Numerous Countries 21

4.4 Opportunity 22

4.4.1 Development Of New Drugs 22

4.5 Product Pipeline Analysis 22

4.5.1 Introduction 22

4.5.2 NT-ProBNP Selected Prevention Of Cardiac Events In Diabetic Patients 23

4.5.3 Testing Ramipril To Prevent Memory Loss In People With Glioblastoma 23

4.5.4 Ramipril Treatment Of Claudication 24

4.5.5 Bariatric Surgery And Pharmacokinetics Of Ramipril 24

5 Market Factor Analysis

5.1 Value Chain Analysis 25

5.1.1 R&D And Designing 25

5.1.2 Manufacturing 25

5.1.3 Distribution & Sales 25

5.1.4 Marketing & Sales 26

5.1.5 Post-Sales Review 26

5.2 Porter’s Five Forces Model 26

5.2.1 Bargaining Power Of Suppliers 28

5.2.2 Bargaining Power Of Buyers 28

5.2.3 Threat Of New Entrants 28

5.2.5 Intense Rivalry 28

5.3 Specifications & Purity Requirements 29

5.4 Patent Analysis 30

5.4.1 Introduction 30

5.5 Regulatory Analysis 31

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/prils-market-7692

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

collect
0
avatar
Mayur Kasrung
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more